Place des nouveaux antidiabétiques dans la population gériatrique [Use of new antidiabetics in the elderly population].

Détails

ID Serval
serval:BIB_F072D879DB14
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Place des nouveaux antidiabétiques dans la population gériatrique [Use of new antidiabetics in the elderly population].
Périodique
Revue Médicale Suisse
Auteur(s)
Besse S., Besse A., Jornayvaz F.R.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2016
Peer-reviewed
Oui
Volume
12
Numéro
521
Pages
1101-1106
Langue
français
Résumé
Over the last few years, we have noticed the arrival on the market of new antidiabetic treatments. These represent an potential advantage because of the increase in the prevalence of type 2 diabetes, particularly in the elderly population. Nevertheless, elderly patients have a number of frailties that should be considered in the treatment of this condition. There is a lack of literature in this population as elderly are frequently excluded from randomized controlled trials. Therefore, guidelines were developed based on the consensus of experts in geriatrics and diabetology for this specific population. We have to consider the potential benefits and adverse effects of the new antidiabetics in older patients.
Mots-clé
Aged, Diabetes Mellitus, Type 2/drug therapy, Frail Elderly, Geriatric Assessment, Health Status, Humans, Hypoglycemic Agents/therapeutic use
Pubmed
Création de la notice
13/09/2016 14:31
Dernière modification de la notice
03/03/2018 22:36
Données d'usage